Variantes patogênicas e alteração da expressão em genes candidatos ao espectro óculo-aurículo-vertebral

Detalhes bibliográficos
Ano de defesa: 2018
Autor(a) principal: Souza, Malu Zamariolli de [UNIFESP]
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de São Paulo (UNIFESP)
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=7044167
https://repositorio.unifesp.br/handle/11600/52320
Resumo: Objective: To investigate the presence of alterations in the sequence and expression of candidate genes in a cohort of 73 patients diagnosed with oculoauriculovertebral spectrum (OAVS). Methods: Next generation sequencing of exons and untranslated regions (UTRs) from ten candidate genes (YPEL1, MAPK1, CRKL, OTX2, GSC, HMX1, NKX32, MYT1, PUF60 and HOXA2) was performed. Single nucleotide variants (SNVs) were analyzed by several in silico prediction tools and classified into three categories: likely benign, variant of uncertain significance and likely pathogenic. Variants considered as likely pathogenic were validated by Sanger sequencing and their heritability was accessed when parents’ DNA was available. Whole blood expression of the genes containing likely pathogenic variants was evaluated in the patients and compared to a group of control individuals. Results: Six SNVs were considered as likely pathogenic. All of them were in heterozygous state and were localized in the UTRs regions of five sequenced candidate genes (YPEL1, MAPK1, CRKL, OTX2 and MYT1). Variants in the YPEL1, MAPK1, CRKL and OTX2 genes were identified in five unrelated patients, two with variants in YPEL1. In contrast, the variant located in the MYT1 gene was identified in five other unrelated patients. The impact of variants in the YPEL1, MAPK1, CRKL and MYT1 genes on the expression in peripheral blood was verified, however, gene expression analysis showed unmodified transcription levels in the patients when compared to controls. Conclusion: Novel variants in candidate genes were described and they may help to improve the understanding of the complex and unknown etiology of OAVS. The fact that each variant was only identified in one or a few patients supports the hypothesis of the genetic heterogeneity of the spectrum and a probable multifactorial inheritance with different factors involved in the disease, including environmental factors.